Factors associated with the use of wheelchairs by institutionalized elderly people

Resumo Devido à alta prevalência do uso de cadeira de rodas por idosos institucionalizados, objetivou-se verificar se os fatores sexo, idade, escolaridade, tempo de admissão, comorbidades, cognição e funcionalidade estão associados ao uso deste dispositivo, como também averiguar os motivos que podem levar a essa utilização segundo a percepção dos idosos. Estudo transversal e descritivo, incluídos 55 idosos subdivididos em G1 (locomoção sem auxílio) e G2 (cadeirantes). Análise do perfil através dos prontuários, cognição e funcionalidade pelo Mini-Exame do Estado Mental e Índice de Barthe l. Foram questionados 33(60,0%) cadeirantes no G1 e 22(40,0%) no G2 sobre os fatores que os levaram à utilização da cadeira de rodas. Houve diferença entre os grupos em relação à funcionalidade (p = 0,005). O idoso que não tem acidente vascular encefálico tem menor chance de utilizar cadeir a de rodas (OR:0,09; IC95%:0,02-0,36). Idosos cadeirantes relataram: medo de cair, dor, cansaço, fraqueza nas pernas, dificuldades de caminhar e falta de auxílio na deambulação. O acidente vascular encefálico e a funcionalidade estão associados ao uso de cadeira de rodas. O conhecimento destes fatores e dos motivos relatados pelos idosos pode permitir que alter...
Source: Ciencia e Saude Coletiva - Category: Occupational Health Source Type: research

Related Links:

Sickle cell disease (SCD) is the most commonly inherited genetic blood disorder, affecting nearly 100,000 children and adults in the United States. Three million Americans carry the sickle cell trait and it is nearly25 times more common in people of African American descent. The disorder, which can cause irregularly shaped blood cells to get stuck in narrow vessels, inflicts substantial pain on patients. The resulting reduced oxygen flow creates life-threatening complications such as difficulty breathing, chest pains, blood clots and stroke.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Rare Diseases Pelosi Plan Source Type: news
Abstract Sigma 1 receptor (σ1), a small transmembrane protein expressed in most human cells participates in modulating the function of other membrane proteins such as G protein coupled receptors and ion channels. Several ligands targeting this receptor are currently in clinical trials for the treatment of Alzheimer's disease, ischemic stroke and neuro-pathic pain. Hence, this receptor has emerged as an attractive target for the treatment of neuro-pathological diseases with unmet medical needs. It is of interest to identify and characterise novelσ1 receptor ligands with different chemical scaffolds usin...
Source: Bioinformation - Category: Bioinformatics Authors: Tags: Bioinformation Source Type: research
Publication date: Available online 12 November 2019Source: Progress in NeurobiologyAuthor(s): Joseph H. Neale, Tatsuo YamamotoAbstractN-Acetylaspartylglutamate (NAAG) is the third most prevalent neurotransmitter in the mammalian nervous system, yet its therapeutic potential is only now being fully recognized. Drugs that inhibit the inactivation of NAAG by glutamate carboxypeptidase II (GCPII) increase its extracellular concentration and its activation of its receptor, mGluR3. These drugs warrant attention, as they are effective in animal models of several clinical disorders including stroke, traumatic brain injury and schi...
Source: Progress in Neurobiology - Category: Neuroscience Source Type: research
Photo Image Caleb George Dear Carol: Both of my parents were ill for years. Mom, who died two years ago, fought several types of cancer and then developed dementia. Dad, who died three months ago, had a massive stroke right after Mom’s death and his last years were full of physical and emotional pain. My brother and I grieve our parents, but we saw them wear out from health struggles and feel that they are now together in a better place, so there’s quite of bit of relief, as well. Knowing our parents are no longer suffering is part of the relief, but I’m also relieved that I can now spend more time w...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
AbstractPurpose of ReviewTo provide an overview of the current treatment strategies for common subtypes of post-stroke pain.Recent FindingsThere is growing research interest in non-pharmacological treatment approaches for chronic pain, including neurostimulation as well as lifestyle and psychosocial interventions. Newer pharmacotherapy research includes cannabinoids and NMDA-receptor antagonists as well as bee venom. Persistent post-stroke headache is an increasingly appreciated entity, though the role of novel chronic migraine treatments for post-stroke headache is not known.SummaryOverall, most treatment approaches to po...
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research
[Lysophosphatidic Acid Receptor Signaling Underlying Chronic Pain and Neuroprotective Mechanisms through Prothymosin α]. Yakugaku Zasshi. 2019;139(11):1403-1415 Authors: Ueda H Abstract For my Ph.D. research topic, I isolated endogenous morphine-like analgesic dipeptide, kyotorphin, which mediates Met-enkephalin release, and discovered kyotorphin synthetase, a putative receptor and antagonist. Furthermore, I succeeded in purifying μ-opioid receptor and functional reconstitution with purified G proteins. After receiving my full professor position at Nagasaki University in 1996, I worked on two...
Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - Category: Drugs & Pharmacology Authors: Tags: Yakugaku Zasshi Source Type: research
Conclusion:Transfer for PCI without thrombolytics is best if PCI at receiving facility can be done in less than 120 minutes from first medical contact, or less than 90 minutes from STEMI diagnosis in first ED.Thrombolytics prior to Transfer to a PCI capable facility, then rescue PCI if no reperfusion for STEMITRANSFER AMI(Cantor et al. 2009).High risk STEMI: BP less than 100, HR greater than 100 Killip class II, III, ST depression of at least 2 mm in precordial leads, ST elevation in right precordial leads (right ventricular MIAll patients get TNK-tPA.80-90% received clopidogrel 300 mg (75 mg for age over 75).Enox...
Source: Dr. Smith's ECG Blog - Category: Cardiology Authors: Source Type: blogs
AbstractObjectiveTo evaluate the efficacy of electro-acupuncture (EA) or transcutaneous electrical acupoint stimulation (TEAS) on perioperative cerebral blood flow (CBF) and neurological function in ischemic stroke (IS) patients undergoing carotid artery stenting (CAS).MethodsIn total, 124 consecutive IS patients were randomly allocated to the EA, TEAS, and sham groups (groups A, T, and S; 41, 42, and 41 cases, respectively) by software-derived random-number sequence. Groups A and T received EA and TEAS, respectively, at the Shuigou (GV 26) and Baihui (GV 20), Hegu (LI4) and Waiguan (TE 5) acupoints. Group S received sham ...
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
ConclusionsThe prevalence of AHF protocols is rather high but the contents seem to vary. Difficulty of diagnosing suspected AHF seems to be moderate compared with other pre ‐hospital conditions.
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Original Research Article Source Type: research
Conditions:   Hypertension;   Diabetes;   Obesity;   COPD;   CHF;   High Cholesterol;   Asthma;   Chronic Pain;   Multiple Sclerosis;   Depression;   Anxiety;   Heart Diseases;   Stroke Interventions:   Behavioral: HeRe We Arts;   Behavioral: HeRe We Ed Sponsors:   The Cleveland Clinic;   National Endowment for the Arts;   Cuyahoga Arts and Culture Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Education | Men | Occupational Health | Pain | Stroke | Study | Universities & Medical Training